Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77


B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection.

Huang KH, Bonsall D, Katzourakis A, Thomson EC, Fidler SJ, Main J, Muir D, Weber JN, Frater AJ, Phillips RE, Pybus OG, Goulder PJ, McClure MO, Cooke GS, Klenerman P.

Nat Commun. 2010 Oct 19;1:102. doi: 10.1038/ncomms1100.


B cell depletion in HIV-1 subtype A infected Ugandan adults: relationship to CD4 T cell count, viral load and humoral immune responses.

Oballah P, Flach B, Eller LA, Eller MA, Ouma B, de Souza M, Kibuuka HN, Wabwire-Mangen F, Brown BK, Michael NL, Robb ML, Montefiori D, Polonis VR.

PLoS One. 2011;6(8):e22653. doi: 10.1371/journal.pone.0022653. Epub 2011 Aug 23.


Early preservation of CXCR5+ PD-1+ helper T cells and B cell activation predict the breadth of neutralizing antibody responses in chronic HIV-1 infection.

Cohen K, Altfeld M, Alter G, Stamatatos L.

J Virol. 2014 Nov;88(22):13310-21. doi: 10.1128/JVI.02186-14. Epub 2014 Sep 10.


Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.

McGuire AT, Glenn JA, Lippy A, Stamatatos L.

J Virol. 2014 Mar;88(5):2645-57. doi: 10.1128/JVI.03228-13. Epub 2013 Dec 18. Erratum in: J Virol. 2015 May;89(9):5194.


Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals.

Corti D, Langedijk JP, Hinz A, Seaman MS, Vanzetta F, Fernandez-Rodriguez BM, Silacci C, Pinna D, Jarrossay D, Balla-Jhagjhoorsingh S, Willems B, Zekveld MJ, Dreja H, O'Sullivan E, Pade C, Orkin C, Jeffs SA, Montefiori DC, Davis D, Weissenhorn W, McKnight A, Heeney JL, Sallusto F, Sattentau QJ, Weiss RA, Lanzavecchia A.

PLoS One. 2010 Jan 20;5(1):e8805. doi: 10.1371/journal.pone.0008805.


Higher homologous and lower cross-reactive Gag-specific T-cell responses in human immunodeficiency virus type 2 (HIV-2) than in HIV-1 infection.

Jennes W, Camara M, Dièye T, Mboup S, Kestens L.

J Virol. 2008 Sep;82(17):8619-28. doi: 10.1128/JVI.00027-08. Epub 2008 Jun 18.


Mimotopes selected by biopanning with high-titer HIV-neutralizing antibodies in plasma from Chinese slow progressors.

Zhang X, Han X, Dai D, Bao M, Zhang Z, Zhang M, Bice T, Zhao M, Cao Y, Shang H.

Braz J Infect Dis. 2012 Nov-Dec;16(6):510-6. doi: 10.1016/j.bjid.2012.07.003. Epub 2012 Nov 9.


Regulatory T cell suppression of Gag-specific CD8 T cell polyfunctional response after therapeutic vaccination of HIV-1-infected patients on ART.

Macatangay BJ, Szajnik ME, Whiteside TL, Riddler SA, Rinaldo CR.

PLoS One. 2010 Mar 24;5(3):e9852. doi: 10.1371/journal.pone.0009852.


Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection.

Draenert R, Verrill CL, Tang Y, Allen TM, Wurcel AG, Boczanowski M, Lechner A, Kim AY, Suscovich T, Brown NV, Addo MM, Walker BD.

J Virol. 2004 Jan;78(2):630-41.


Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.

Wu X, Yang ZY, Li Y, Hogerkorp CM, Schief WR, Seaman MS, Zhou T, Schmidt SD, Wu L, Xu L, Longo NS, McKee K, O'Dell S, Louder MK, Wycuff DL, Feng Y, Nason M, Doria-Rose N, Connors M, Kwong PD, Roederer M, Wyatt RT, Nabel GJ, Mascola JR.

Science. 2010 Aug 13;329(5993):856-61. doi: 10.1126/science.1187659. Epub 2010 Jul 8.


Early development of broadly neutralizing antibodies in HIV-1-infected infants.

Goo L, Chohan V, Nduati R, Overbaugh J.

Nat Med. 2014 Jun;20(6):655-8. doi: 10.1038/nm.3565. Epub 2014 May 25.


HIV-1 MN Env 15-mer peptides better detect HIV-1 specific CD8 T cell responses compared with consensus subtypes B and M group 15-mer peptides.

Rutebemberwa A, Currier JR, Jagodzinski L, McCutchan F, Birx D, Marovich M, Cox JH.

AIDS. 2005 Jul 22;19(11):1165-72.


Immune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients.

Van Gulck E, Bracke L, Heyndrickx L, Coppens S, Atkinson D, Merlin C, Pasternak A, Florence E, Vanham G.

PLoS One. 2012;7(5):e37792. doi: 10.1371/journal.pone.0037792. Epub 2012 May 30.


Profiles of neutralizing antibody response in chronically human immunodeficiency virus type 1 clade B'-infected former plasma donors from China naive to antiretroviral therapy.

Hu X, Hong K, Zhao C, Zheng Y, Ma L, Ruan Y, Gao H, Greene K, Sarzotti-Kelsoe M, Montefiori DC, Shao Y.

J Gen Virol. 2012 Oct;93(Pt 10):2267-78. doi: 10.1099/vir.0.043802-0. Epub 2012 Jul 12.


Post-infection immunodeficiency virus control by neutralizing antibodies.

Yamamoto H, Kawada M, Takeda A, Igarashi H, Matano T.

PLoS One. 2007 Jun 20;2(6):e540.


HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads.

Mabuka J, Nduati R, Odem-Davis K, Peterson D, Overbaugh J.

PLoS Pathog. 2012;8(6):e1002739. doi: 10.1371/journal.ppat.1002739. Epub 2012 Jun 14.


CD4+ T cells drive goblet cell depletion during Citrobacter rodentium infection.

Chan JM, Bhinder G, Sham HP, Ryz N, Huang T, Bergstrom KS, Vallance BA.

Infect Immun. 2013 Dec;81(12):4649-58. doi: 10.1128/IAI.00655-13. Epub 2013 Oct 7.


Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizing-antibody response in an HIV-1 subtype C-infected individual.

Gray ES, Moody MA, Wibmer CK, Chen X, Marshall D, Amos J, Moore PL, Foulger A, Yu JS, Lambson B, Abdool Karim S, Whitesides J, Tomaras GD, Haynes BF, Morris L, Liao HX.

J Virol. 2011 Aug;85(15):7719-29. doi: 10.1128/JVI.00563-11. Epub 2011 May 25.


Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies.

Oxenius A, Price DA, Trkola A, Edwards C, Gostick E, Zhang HT, Easterbrook PJ, Tun T, Johnson A, Waters A, Holmes EC, Phillips RE.

J Infect Dis. 2004 Aug 15;190(4):713-21. Epub 2004 Jul 20.

Items per page

Supplemental Content

Support Center